SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy cocktail shows promise for tough lung cancer
Disease control OngoingThis study tests a combination of two immune-boosting drugs (zimberelimab and domvanalimab) as a first treatment for people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. The goal is to see if the combo helps control the cancer longer tha…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
Custom-Made vaccine targets tough cancers in early trial
Disease control TerminatedThis early-phase trial tests a personalized vaccine (PANDA-VAC) made from a patient's own tumor mutations, given alongside the immunotherapy drug pembrolizumab. The study includes up to 6 adults with advanced squamous lung or head/neck cancer that cannot be cured. The main goal i…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:54 UTC